Medtronic PLC MDT
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Medtronic PLC (MDT) Free cash flow margin
Medtronic PLC's free cash flow margin over the twelve months to 31 July 2026 was 16.3%, up 1.4 percentage points from fiscal 2026 (14.9%). Over the past ten years it has ranged from 12.1% (fiscal 2018) to 21.4% (fiscal 2015); the current reading is higher than 33% of that period. That is above the Medical Devices industry median of −7.24% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Annual
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2026 | 14.9% | (0.54) |
| FY2025 | 15.5% | (0.61) |
| FY2024 | 16.1% | 1.40 |
| FY2023 | 14.7% | (4.20) |
| FY2022 | 18.9% | 2.65 |
| FY2021 | 16.2% | (4.60) |
| FY2020 | 20.8% | 1.60 |
| FY2019 | 19.2% | 7.15 |
| FY2018 | 12.1% | (6.87) |
| FY2017 | 18.9% | 4.47 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| DXCM DexCom, Inc. compare | 28.3% |
| EW Edwards Lifesciences Corporation compare | 22.0% |
| SYK Stryker Corporation compare | 18.2% |
| BSX Boston Scientific Corporation compare | 17.3% |
| ABT Abbott Laboratories compare | 16.8% |
| MDT Medtronic PLC | 16.3% |
| STE STERIS plc compare | 15.5% |
| PHG Koninklijke Philips N.V. compare | 8.99% |
| GEHC GE HealthCare Technologies Inc. compare | 7.42% |
| Medical Devices industry median | −7.24% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement